Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.13 USD
Change Today +0.04 / 0.98%
Volume 1.6M
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 4:30 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for geron corp (GERN)

Geron Corporation be considered to have little financial risk as the capital structure does not rely on leverage.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents16.122.113.042.8
Short-Term Investments105.273.552.2108.6
TOTAL CASH AND SHORT TERM INVESTMENTS121.395.565.2151.4
Other Receivables1.40.80.61.0
TOTAL RECEIVABLES1.40.80.61.0
Prepaid Expenses2.11.30.50.7
Restricted Cash0.80.80.80.3
TOTAL CURRENT ASSETS125.698.467.1153.4
Gross Property Plant and Equipment18.513.51.31.4
Accumulated Depreciation-17.3-12.5-1.2-1.2
NET PROPERTY PLANT AND EQUIPMENT1.21.00.10.2
Long-Term Investments32.1----18.9
Other Long-Term Assets1.00.40.2--
TOTAL ASSETS160.099.867.3172.5
    
LIABILITIES & EQUITY    
Accounts Payable3.03.41.41.0
Accrued Expenses6.78.75.75.8
Other Current Liabilities, Total3.82.00.50.0
Unearned Revenue, Current------35.0
TOTAL CURRENT LIABILITIES13.414.17.641.8
TOTAL LIABILITIES13.414.17.641.8
Common Stock0.10.10.10.2
Additional Paid in Capital932.1939.9952.41,059.1
Retained Earnings-785.5-854.4-892.8-928.4
Comprehensive Income and Other-0.10.00.0-0.1
TOTAL COMMON EQUITY146.685.759.8130.7
TOTAL EQUITY146.685.759.8130.7
TOTAL LIABILITIES AND EQUITY160.099.867.3172.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $4.13 USD +0.04

GERN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTime Inc $3.23 USD +0.08
Neuralstem Inc $1.70 USD +0.04
Ocata Therapeutics Inc $4.25 USD +0.02
ReNeuron Group PLC 5.63 GBp -0.125
StemCells Inc $0.41 USD -0.0142
View Industry Companies
 

Industry Analysis

GERN

Industry Average

Valuation GERN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 529.9x
Price/Book 5.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 411.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.